Cat.#: ACPP-1629
| Despition | GDF7 Human Recombinant |
| SIZE | 2 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1366 | Dopamine D5 Receptor Blocking Peptide (AC1366) | 250 µg | inquiry |
| ACPP-1079 | Dopamine Receptor D1 Blocking Peptide (AC1079) | 250 µg | inquiry |
| ACPP-1594 | Human CCM2 Protein (AC1594) | 2 µg | inquiry |
| ACPP-1044 | Recombinant Human RAGE Protein (6×His Tag) (AC1044) | 50 µg | inquiry |
| ACPP-1030 | Recombinant Human Acetylcholinesterase Protein (6×His Tag) (AC1030) | 50 µg | inquiry |
| ACPP-1633 | Human PTPS Protein (AC1633) | 5 µg | inquiry |
| ACPP-1003 | Recombinant Human NOTCH3 Protein (Fc Tag) (AC1003) | 50 µg | inquiry |
| ACPP-1832 | Human CRYZ Protein (AC1832) | 5 µg | inquiry |
| ACPP-1088 | Synthetic Exosome Human CD24 Protein (AC1088) | 50 µg | inquiry |
| ACPP-1647 | Human TUBB3 Protein (AC1647) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.